In this group, 5 patients (83%) had a treatable inherited neurotransmitter disorders including GTPCH deficiency, PTPS deficiency, DHPR deficiency, PDE-ALDH7A1 and PNPO deficiency. This evidence concerns the gene ALDH7A1 and dihydropteridine reductase deficiency.